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Little is known about the formation of the interventricular septum (IVS), a central event during cardiogenesis. Here, we describe a novel
population of myocardial progenitor cells in the primitive ventricle of the mouse embryo, which is characterized by expression of lysozyme M
(lysM). Using LysM-Cre mice we show that lysozyme expressing cells give rise to the IVS and to a part of the left ventricular free wall,
demonstrating that these heart regions are developmentally related. LysM+ precursors are not of hematopoietic origin and develop in the absence
of transcription factors that regulate lysozyme expression in macrophages. LysM-deficient mice lack an overt cardiac phenotype, perhaps due to
compensation by the related lysozyme P, which we also found to be expressed in the developing heart. Direct visualization of lysM expression,
using LysM-EGFP knock-in mice, showed that ventricular septation is initiated at embryonic day 9 by the movement of myocardial trabeculae
from the primitive ventricle towards the bulbo-ventricular groove and revealed the dynamics of IVS formation at later stages. Our studies predict
that LysM-Cre mice will be useful to inactivate genes in the developing IVS.
© 2006 Elsevier Inc. All rights reserved.Keywords: Lysozyme; Heart development; Interventricular septation; Lineage tracing; Heart morphogenesis; CardiomyocytesIntroduction
The heart is the first organ that forms during mammalian
development, satisfying the oxygen and nutrients needs of the
growing embryo. The mature heart consists of two atria and two
ventricles, the latter of which are separated by the interventric-
ular septum (IVS). Ventricular septal defects are among the
most common congenital heart lesions (Vaughan and Basson,
2000). Nevertheless, the knowledge about the origin of the IVS
as well as of the dynamics and the control of its development
remains sparse.
The first morphological evidence of cardiogenesis is the
cardiac crescent, which forms in the mouse embryo at about
embryonic day 7.5 (E7.5) from anterior mesoderm (Bucking-
ham et al., 2005). Shortly thereafter the cardiac crescent fuses to
give rise to the linear heart tube, which starts beating around E8,
when extra-embryonic and embryonic vascular networks
amalgamate (McGrath et al., 2003). The heart tube undergoes⁎ Corresponding author. Fax: +1 718 430 3305.
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four-chambered adult organ. During the initial remodeling steps
between E8.5 and E10.5, the cardiac chambers become evident
as a consequence of the forward looping of the posterior parts of
the heart tube and the thickening of the myocardium
(Buckingham et al., 2005). The chambers then get physically
separated by the growth of the septae and valves, thereby
allowing for directed flow of the blood stream. The developing
heart is subdivided by the formation of the IVS, which is located
between the left and right ventricles. IVS formation in the
mouse occurs approximately between E11 and E12.5 and
involves the recruitment of myocardial cells as well as of non-
muscular mesenchymal cells (Kaufman and Bard, 1999).
Dye injection experiments in chicken embryos showed that
cardiomyocytes in the IVS are derived from the region of the
bulbo-ventricular groove (de la Cruz et al., 1997). This structure
demarcates the separation between the embryonic left and right
ventricle and becomes detectable at about E10 in the mouse
embryo. The analysis of staged chicken embryos suggested that
the IVS forms by the coalescence of individual muscle fiber
bundles – so-called trabeculae – present in the primitive left
ventricle (Ben-Shachar et al., 1985). However, this study did not
196 M. Stadtfeld et al. / Developmental Biology 302 (2007) 195–207address where IVS precursors reside prior to formation of the
bulbo-ventricular groove. Elegant lineage tracing experiments
in the mouse indicate that the myocardium of the IVS has a dual
origin, being derived partly from the right and partly from the
left ventricular primordium (Meilhac et al., 2004). A number of
genes have been implicated in IVS formation. Thus, mice with
targeted deletions of the transcription factors Tbx5 (Takeuchi
et al., 2003) and SRF (Parlakian et al., 2004) as well as of the
chemokine receptor CXCR4 (Tachibana et al., 1998; Zou et al.,
1998) and its ligand SDF-1 (Nagasawa et al., 1996) all have
ventricular septal defects. However, because specific gene
ablation in the IVS is not yet possible it cannot be ruled out that
the observed phenotypes are secondary to one of the many
cardiac and systemic abnormalities in these animals.
Lysozyme is a bacteriolytic enzyme that is part of the innate
immune system. Mice have two closely related lysozyme genes:
LysM (Lyzs, called lysM in the following), which is expressed
in macrophages and granulocytes (Cross et al., 1988) as well as
type II alveolar epithelial cells in the lung (Rehm et al., 1991).
And lysP (Lzp-s, called here lysP), which is expressed in the
Paneth cells of the small intestine (Cross et al., 1988). Here, we
report the surprising finding that lysM is also expressed
transiently in a novel population of myocardial precursors of
the IVS. The study of a mouse model with a knock-in of egfp
into the endogenous lysM locus (Faust et al., 2000) allowed us
to directly visualize the dynamics of IVS formation. In addition,
we traced the developmental fate of lysM+ myocardial cells by
Cre/loxP technology. Our study shows that IVS precursors are
determined before septation is initiated and that the muscular
compartment of the IVS is derived from at least two types of
progenitor cells. In addition, our work suggests that cardiac-
specific mechanisms of lysozyme regulation exist and that this
enzyme has hitherto unknown functions in the heart.Materials and methods
Mice
LysM ancestry (Ye et al., 2003) and LysM-EGFP (Faust et al., 2000) mice
were used as homozygotes for the LysM-Cre and LysM-EGFP alleles,
respectively. Vav ancestry mice (Stadtfeld and Graf, 2005) were heterozygous
for vav-Cre. LysM ancestry mice were homozygous for ROSA26R-YFP or
ROSA26R-lacZ (Soriano, 1999; Srinivas et al., 2001), respectively. Lysozyme
ancestry mice lacking PU.1 were obtained by crossing them for two generations
to animals heterozygous for a germ line deletion of PU.1 (Ye et al., 2005).
Similarly, LysM-EGFP mice lacking C/EBPβ were generated by crossed them
with C/EBPβ mutant mice (Sterneck et al., 1997). All genotyping was
performed as previously described (see above references). Mice were bred and
maintained in accordance with guidelines from the Institute for Animal Studies
of the Albert Einstein College of Medicine.
X-gal and EGFP whole mounts
For X-gal whole mounts of adult hearts, mice were anesthetized with
isoflurane and perfused into the left ventricle with PBS followed by 1.5%
paraformaldehyde (PFA, Electron Microscope Science), before hearts were
dissected and fixed in 1.5% PFA overnight at 4°C. Fixed hearts were incubated
in X-gal staining solution containing 1 mg/ml of X-gal (5-bromo-4-chloro-3-
indolyl-βD-galactoside, FisherBiotech) in 2 mM MgCl2, 5 mM K3Fe(CN)6,
5 mM K4Fe(CN)6 and 0.02% NP40 in PBS, pH 7.4 for 12–24 h in the dark at37°C. Imaging was done using a Nikon SMZ 1500 dissection microscope
equipped with an Insight FireWire camera and SPOT imaging software
(Diagnostic Instruments). To render hearts transparent they were dehydrated
through a methanol series followed by incubation in a 2:1 mixture of benzyl
benzoate: benzyl alcohol (Rentschler et al., 2001).
For EGFP whole mounts of the developing heart embryos were obtained
from timed matings with the noon of the day of the vaginal plug designated
embryonic day 0.5 (E0.5). The developmental stage was verified by counting
somite pairs (between E8.5 and E11.5) or by other morphological criteria
(Downs and Davies, 1993). Embryonic hearts were isolated with microdissec-
tion tweezers (Roboz Surgical) by clipping the distal part of the outflow tract and
the two horns of the sinus venosus. For EGFP visualization, hearts were
mounted in a drop of PBS and imaged with a Nikon Eclipse E600 microscope
equipped with a FITC filter (Chroma #41001) and a MagnaFire (Optronics,
Goleta, CA) camera. Image processing was done in Adobe Photoshop.
Preparation and analysis of frozen sections
Anesthetized adult mice were perfused into the left ventricle with PBS
followed by 4% PFA. Dissected hearts were fixed in 1.5% PFA containing 30%
sucrose for 1 h at 4°C, then they were cut in half and incubated for another 8–
12 h in the fixation solution. Embryos and newborn mice were fixed as a whole
for 6 h to overnight, depending on the developmental stage. For embryos older
than E12.5, the head was removed to allow better penetration of the fixative.
Tissues were embedded in O.C.T. compound (Sakura, Torrance, CA) and
submerged in 2-methylbutane at −80°C. 10-μm sections were cut using a Leica
CM1900 cryostat, transferred onto pre-cleaned glass slides (Superfrost/Plus,
Fisher Scientific) and stored at −80°C.
Immunofluorescence was performed using the M.O.M. basic kit (Vector
Labs, Burlingame, CA) following the manufacturer's instructions with the
additional inclusion of 0.3% Triton-100 in all solutions and of 3% BSA and 5%
goat serum in the blocking solution. Antibodies used were mouse-monoclonal
anti α-actinin (Sigma) followed by an Alexa Fluor 546®-conjugated goat anti-
mouse antibody (Invitrogen) as well as APC-conjugated rat monoclonal
antibodies against mouse CD31, CD45, Mac-1, Gr1 (Pharmingen) and F4/80
(Caltag, Burlingame, CA). GFP and YFP signals were sometimes amplified
using an Alexa Fluor 488®-conjugated rabbit anti-GFP antibody (Invitrogen).
DAPI (0.4 μg/ml) was included to visualize nuclei. Sections were observed
under a Nikon Eclipse E600 microscope equipped with filters to visualize DAPI
(Chroma #31000), GFP or Alexa Fluor® 488 (Chroma #41001), YFP (Chroma
#41028), Alexa Fluor® 546 (Chroma #41002c) and APC (Chroma #41013).
Images were taken using a MagnaFire camera (Optronics) and analyzed with
Adobe Photoshop software. For the calculation of the proportion of reporter
labeled cardiomyocytes in vav ancestry mice it was assumed that the adult
murine heart contains a total of 1.9×106 cardiomyocytes (Brodsky et al., 1985).
Sections containing 10,000 to 50,000 cardiomyocytes were analyzed per vav
ancestry mouse.
Real-time PCR analysis
Hearts were dissected from E9.5 (19–24 somite pairs) LysM-EGFP and
C57BL/6 embryos and common atrial chamber, outflow tract and large parts
of the bulbus cordis were dissected away. Repeated washing steps removed
contaminating maternal and embryonic blood cells. RNA was extracted from
pools of 3–5 hearts using the QIAGEN RNeasy Micro Kit following the
manufacturers' instructions. Reverse transcription was done with the iSelect
cDNA Synthesis Kit (Bio-Rad) and real-time PCR reactions were performed
in triplicates with an Opticon2 (MJ Research) using AmpliTag Gold (Roche)
and SybrGreen (Applied Biosystems). The input cDNA amount for each
reaction was equivalent to 1/20 to 1/10 of one dissected embryonic heart. The
following primer pairs were used: 5′-GGAATGGCTGGCTACTATGG-3′ and
5′-TGCTCTCGTGCTGAGCTAAA-3′ (lysM), 5′-ATGGCTACCGTGGTGT-
CAAG-3′ and 5-CGGTCTCCACGGTTGTAGTT-3′ (lysP), and 5′-GACGGC-
CAGGTCATCACTATTG-3′ and 5′-AGGAAGGCTGGAAAAGAGCC-3′ (β-
actin). The PCR efficiency with all primer pairs was >90%. Specificity of
lysM and lysP detection was tested by digestion of the PCR products with
HaeIII, which only cuts lysM.
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A subset of adult cardiomyocytes is derived from lysM
expressing cells
To trace the developmental fate of hematopoietic cells of the
granulocyte/macrophage lineage we used mice with a knock-in
of Cre recombinase into the endogenous lysM locus (Clausen
et al., 1999). These mice were crossed with two conditional
reporter mouse strains (Soriano, 1999; Srinivas et al., 2001). In
the resulting LysM ancestry mice the progeny of lysozyme
expressing cells are irreversibly labeled by either yellow-
fluorescent protein (YFP) or β-galactosidase (β-gal) (Fig. 1A).
As expected, LysM ancestry mice showed reporter geneFig. 1. X-gal labeling in the heart of adult LysM ancestry mice. (A) Breeding schem
expressing cells. (B) X-gal stained whole mounts of hearts from an adult LysM anc
interventricular septum; LV, left ventricle; RV, right ventricle. (C–E) X-gal stained
orientation. Note the complete absence of reporter labeled cardiomyocytes in the rightexpression in essentially all granulocytes and monocytes (Ye
et al., 2003) as well as in tissue macrophages and lung epithelial
cells (data not shown).
A detailed examination of LysM ancestry mice with the lacZ
reporter gene by whole-mount X-gal staining surprisingly
revealed that large parts of the heart muscle were reporter-
positive (Fig. 1B). The pattern of labeling in the cardiac whole
mounts showed the highest density in the vertical midline,
where the IVS is located. From there the labeling extended both
into the anterior and posterior side of the left ventricular free
wall while the atria, the right ventricle as well as the distal part
of the left ventricular free wall were negative (Fig. 1B and data
not shown). Analysis of serial heart sections showed the
presence of reporter labeled cells with the morphology ofe to generate LysM ancestry mice, which allow tracing of the progeny of lysM
estry (left) and a ROSA26R-lacZ mouse used as negative control (right). IVS,
sections through hearts of LysM ancestry mice in coronal and (F) transverse
ventricle and atria. (G) Scheme to illustrate the planes of sectioning in panels C–F.
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prevalence in the part of the myocardium that faces the lumen of
the left ventricle (Fig. 1C). Anteriorly and posteriorly from the
midline, reporter labeled cells were also found in the left
ventricular free wall, especially towards the base of the heart
(Fig. 1D). Longitudinal sections close to the anterior and
posterior ends of the heart muscle showed that reporter labeling
marked the extension of the IVS into this region (Fig. 1E).
Cross-sections further confirmed the total absence of labeled
cardiomyocytes in the right ventricle and the distal end of the
left ventricular free wall (Fig. 1F).
To better characterize the reporter gene expressing cells, we
analyzed heart sections of adult LysM ancestry mice using eyfp
as a reporter gene. This showed that large numbers of
interventricular cardiomyocytes, identified by their morphology
and the expression of the muscle marker α-actinin, were indeed
YFP labeled (Figs. 2A–E). In addition to their mentioned
asymmetric distribution in the IVS, reporter labeled cardio-
myocytes often formed clusters of muscle fibers that showed a
different orientation than neighboring reporter-negative cardi-
omyocytes (Fig. 2A). This indicates that these cells are distinct
developmental and/or functional units of the heart muscle.
YFP+ cardiomyocytes were negative for the macrophage
markers CD45, F4/80, Mac-1 and Gr1 (Figs. 2C–E) and the
endothelial marker CD31 (data not shown). No GFP expression
was detected in cardiomyocytes of adult LysM-EGFP mice (Figs.
2F, G), demonstrating that lysM is not expressed in these cells.
Interventricular cardiomyocytes are not derived from
hematopoietic cells
We next addressed whether the labeling seen in LysM
ancestry mice results from hematopoietic-to-cardiac conver-
sions, which have been reported to occur at high frequency after
bone marrow transplantation into adult recipients (Orlic et al.,
2001). Such conversions remain highly controversial (Balsam et
al., 2004; Murry et al., 2004). To this end we analyzed the hearts
of vav ancestry mice, in which essentially all hematopoietic
cells, including stem and progenitor cells, are irreversibly
labeled both in embryos and in adults and therefore can be
traced (Stadtfeld and Graf, 2005). In these mice no macro-
scopically detectable reporter gene labeled cardiomyocytes
were detected in the IVS or in any other heart region (Suppl.
Fig. 1A). Nevertheless, analysis of frozen sections revealed that
1:5000 to 1:2000 cardiomyocytes are YFP+ in vav ancestry
mice (Suppl. Figs. 1B–D). These cells were not confined to a
particular region of the myocardium. Together, these observa-
tions show that the labeled cardiomyocytes in the hearts of
LysM ancestry mice are not of hematopoietic origin, but raise
the possibility that rare hematopoietic-to-cardiomyocyte con-
versions occur.
As expected, CD45+Mac-1+ hematopoietic cells present in
the heart muscle of LysM ancestry mice were also YFP labeled
(Fig. 2E). These cells, which actively expressed lysM as well as
the CSF-1 receptor (Fig. 2F and data not shown), were found
throughout the heart in surprisingly high numbers, most
abundantly in the atria and the inner surface of the ventricularchambers (Suppl. Fig. 2). Strikingly, in the IVS and the ventricle
walls, these tissue macrophages were organized in a parallel
fashion to cardiomyocytes, often directly overlying them (Fig.
2F and Suppl. Fig. 2D). Similar cells were also reporter labeled
in vav ancestry mice (data not shown).
Myocardial precursor cells express lysM in the embryonic
heart
To determine when during heart development lysM is
expressed, we analyzed LysM-EGFP embryos at different
developmental stages by whole-mount fluorescence microsco-
py. No GFP expression could be detected up to embryonic day
E8.5 (10–12 somite stage) (data not shown). However, at E9.5
strong GFP fluorescence was seen in the heart while no GFP+
hematopoietic cells were present in circulation or the liver
rudiment (Figs. 3A, B). Imaging of dissected hearts between E9
and E9.5 showed that GFP+ cells initially (15 somite stage)
formed an almost continuous ring that was perpendicular to the
anterior–posterior axis of the heart tube. Soon thereafter (19
somite stage) two domains of strong GFP expression became
visible within this ring: a dorsal domain close to the outflow tract
and the common atrial chamber and a ventral domain, extending
from the forming bulbo-ventricular groove into the primitive
ventricle (Figs. 3C–E). Sections through an E10 embryo (25
somite stage) showed that GFP+ cells localized to muscular
protrusions of the heart muscle, so called trabeculae, in the
primitive ventricle (Figs. 3F–H). No GFP+ cells were seen in
other regions of the developing heart. Immunofluorescence
staining on sections of an E9 (17 somite stage) embryo showed
that all GFP+ cells present in the heart expressed the muscle
marker α-actinin (Fig. 4) while none of them expressed the
endothelial marker CD31 or the hematopoietic markers CD45,
Mac-1 and F4/80 (data not shown). These results show that a
subset of myocardial cells in the mouse embryo express lysM.
Lysozyme expression reveals dynamics of IVS formation
To follow the dynamics of cardiac lysozyme expression we
analyzed hearts from E10.5, E11.5 and E13.5 embryos by
whole-mount fluorescence microscopy. At E10.5, the ring of
GFP+ cells extending into the primitive ventricle and its two
domains of GFP expression were still visible (Fig. 5A).
However, compared to E9 (see Fig. 3) the fluorescence intensity
of the ventral domain had increased while that of the dorsal
domain had decreased. This trend continued at E11.5, when
expression in the dorsal domain was almost extinguished and
the ventral domain extended dorsally, visualizing the closure of
the interventricular foramen by the myocardial component of
the IVS (Fig. 5B). At E13.5, when septation is complete,
myocardial lysozyme expression formed a brightly fluorescent
“zipper” between the right and left ventricle, highlighting the
position of the IVS (Fig. 5C). An artistic rendering of these
processes summarizes the dynamics of lysM expression in the
developing heart (Fig. 5, right panel).
To analyze IVS development after E13.5, when the heart
becomes too opaque for whole-mount fluorescent microscopy,
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and LysM ancestry mice. This permitted the simultaneous
visualization of both past and ongoing lysM expression. As
shown in Fig. 6, at E14.5 GFP expression was strongest in the
tip and outer layers of the IVS as well as in trabeculae of the left
ventricle close to the base of the IVS. Essentially all GFP+ cells
were also X-gal+ (compare Figs. 6D and E). This indicates that
activation of the lysM locus was not a very recent event in theseFig. 2. Reporter labeling in heart sections of adult LysM ancestry and LysM-EGFPmic
fluorescence in yellow, α-actinin in red, CD45 in purple and DAPI in blue. (A, B
bar=50 μm. YFP labeled cardiomyocytes are mostly seen on the left side of the IVS.
YFP− fibers are oriented perpendicular to it. (C–E) Magnification of the area boxed in
DAPI and YFP (C), DAPI and α-actinin (D) and DAPI and CD45 (E). An arrow h
through the IVS of a LysM-EGFP mouse showing overlays of GFP (green) and
macrophages. Scale bar=15 μm. Note that cardiomyocytes are GFP-negative.cells since Cre expression is not immediately translated into
detectable reporter activation X-gal+ GFP− cardiomyocytes,
which previously had expressed lysozyme but did not maintain
this expression, were also present. However, they localized to
different parts of the myocardium than cardiomyocytes that still
actively expressed lysozyme: The dorsal region of the heart
separated from the growth area of the IVS by a buffer of X-gal-
negative mesenchymal cells (region I, Figs. 6B, C) and thee. (A–E) Coronal sections through the IVS of a LysM ancestry mouse, with YFP
) Overlay of YFP and brightfield (A) and YFP fluorescence only (B). Scale
Note also that all YFP+ fibers run parallel to the plane of sectioning while most
panels A and B, demonstrating co-expression of YFP and α-actinin. Overlays of
ighlights an YFP+ CD45+ hematopoietic cell. Scale bar=15 μm. (F, G) Section
brightfield and DAPI and CD45, respectively. Arrows indicate GFP+ CD45+
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mice lysM expression was still detectable within a thin layer of
cardiomyocytes surrounding the superior part of the IVS, and
became undetectable after the second postnatal week (data not
shown). Together, these observations show that after ventricular
septation is completed lysozyme expressions continues to be
dynamically expressed in the IVS.Fig. 3. GFP fluorescence in the heart of LysM-EGFP embryos. (A, B) Images showin
overlaying brightfield image. The position of the liver rudiment (liv) is outlined by
bar=250 μm. (C–E) Fluorescent images of hearts from three E9 LysM-EGFP embr
overlays of GFP and brightfield images. The arrows indicate the location of the nasce
expression are indicated. Scale bar=100 μm. (F–H) Frozen sections in transverse orie
red. The dorsal side of the embryo is facing up. Sections move anteriorly from panels
and the asterisks accumulations of red blood cells in the bulbus cordis (bc). Scale ba
ventricle (pv).LysP is also expressed in the embryonic heart
We next determined whether lysP, which shows >90%
identity to lysM at the amino acid level, is also expressed in the
developing heart. To this end we performed quantitative real-
time PCR on cDNA prepared from E9.5 primitive ventricle. At
this stage lysozyme expression is not detectable in circulatingg GFP fluorescence in an E9.5 LysM-EGFP embryo without (A) and with (B) an
a dotted line. ac, Common atrial chamber; hd, head and ot, outflow tract. Scale
yos at different somite pair stages (15 s, 17 s and 19 s). The lower rows show
nt bulbo-ventricular groove. The dorsal (DD) and ventral (VD) domains of GFP
ntation of an E10 (25 s) embryo. GFP fluorescence in green, autofluorescence in
F to G. The arrow indicates the location of the nascent bulbo-ventricular groove
r=60 μm. Note that the GFP labeling is restricted to trabeculae in the primitive
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1999) (see also Figs. 3A, B). This analysis revealed that lysP is
expressed in the developing heart at levels similar to lysM both
in wild type and in lysM-deficient mice (Fig. 7A). In contrast, in
bone marrow lysP expression is only detectable in the absence
of lysM (Fig. 7B). The observed ∼50 fold difference in
expression of lysM in the two tissues examined represents an
overestimate since the percentage of lysozyme expressing cells
is lower in the E9.5 heart (<5%) than in the bone marrow (60–
70%). These results show that both lysM and lysP genes are
expressed in the heart of E9.5 embryos while lysM but not lysP
is expressed in hematopoietic cells.
Cardiac lysM expression does not require PU.1 and C/EBPβ
The expression of lysM in macrophages is controlled by the
PU.1 and C/EBPβ (Faust et al., 1999; Lefevre et al., 2003). To
test whether cardiac lysM expression is similarly regulated we
crossed LysM ancestry with animals containing a targeted
deletion of PU.1 (Ye et al., 2005) and analyzed newborn pups of
the F2 generation by X-gal staining. This revealed no
differences between wild type and homozygous mutant animals
with respect to the abundance and organization of labeledFig. 4. Myocardial nature of lysozyme expressing cells in the heart of LysM-EGFP em
showing GFP fluorescence (green) and staining for α-actinin (red). The arrow in pane
in panel C circulating autofluorescent red blood cells. Scale bar =100 μm. (D–F) Ma
(D), α-actinin and DAPI (blue, E) and GFP fluorescence only (F). Staining with the h
that GFP expression is restricted to cells that express α-actinin. The inserts in panels D
Scale bar=50 μm.cardiomyocytes (Suppl. Figs. 3A–B). As expected, X-gal+
hematopoietic cells were abundant in the liver of wild type mice
but totally absent in the PU.1 knockout animals (Suppl. Figs.
3C–D). Similarly, E11 LysM-EGFP embryos lacking C/EBPβ
showed no reduction in cardiac GFP labeling, while lysozyme
expression in fetal liver macrophages was significantly lowered
(Suppl. Figs. 3E–G).
Discussion
LysM expression defines a novel cardiac progenitor population
of non-hematopoietic origin
Here, we report the unexpected finding that lysM marks a
subset of embryonic myocardial precursors that form large parts
of the interventricular septum as well as portions of the left
ventricle in the adult heart (Fig. 1, see also scheme in Fig. 8).
While lysM is best known for its expression in macrophages,
cardiomyocytes derived from lysM expressing cells are not of
hematopoietic origin. Thus, regions of the heart that are strongly
labeled in LysM ancestry mice are mostly negative in vav
ancestry mice (Suppl. Fig. 1), a model that traces all
hematopoietic lineages and shows an earlier onset of bloodbryos. (A–C) Frozen section through the heart of an E9.5 LysM-EGFP embryo
l A indicates the position of the forming bulbo-ventricular groove and the asterisk
gnification of area boxed in panels A–C showing overlays of GFP and α-actinin
ematopoietic markers CD45, Mac-1 and F4/80 gave no detectable signals. Note
–F show a magnified view of a GFP+ and a GFP−myocardial cell (boxed area).
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2005). The rare reporter-positive cardiomyocytes (1:5000 to
1:2000) in vav ancestry mice might reflect inappropriate
expression of vavCre in cardiomyocytes (or their precursors),
although a hematopoietic origin of the labeled cells cannot be
excluded. The observed frequency of labeled cardiomyocytes in
these mice therefore represents the upper limit of possible
hematopoietic-to-cardiomyocyte conversions during normal
development.Fig. 5. Dynamics of IVS formation as delineated by lysozyme expression. Images of
E13.5 (C) showing GFP fluorescence (green, left panels), overlay of GFP and brightf
The green line and the arrow indicate the location of GFP+ cells and their probable mo
at an earlier stage. Anterior (a), posterior (p), dorsal (d) and ventral (v) orientations are
primitive ventricle; gr, bulbo ventricular groove; la, left atrium; right atrium ra; lv, lef
to the primitive ventricle except for a weak signal originating at E10.5 from the regio
has not been verified in sections of the same region.The myocardial identity of the lysozyme expressing cells in
the developing heart was shown by α-actinin expression and the
cells' morphology, which was indistinguishable from surround-
ing lysM− cardiomyocytes (Figs. 4D–F). The position of
lysM+ cells within the embryonic heart and their contribution to
specific regions of the adult heart establishes them as a novel
population of cardiac precursors. This conclusion is supported
by the pattern of reporter gene expression in LysM-EGFP
embryos, which differs from that of more than a dozenentire hearts dissected from LysM-EGFP embryos at E10.5 (A), E11.5 (B) and
ield (middle panels) as well as schematics interpreting the images (right panels).
vements, while the broken line indicates regions where GFP+ cells were detected
indicated by the cross. ac, Atrial chamber; ot, outflow tract; bc, bulbus cordis; pv,
t ventricle and rv, right ventricle. Note that GFP fluorescence is largely restricted
n of the bulbus cordis (asterisk). The significance of this signal is unclear since it
Fig. 6. Dynamics of lysozyme expression during late stages of IVS formation. (A–C) Transverse section through the heart of an E14.5 LysM-EGFP × LysM lacZ
ancestry mouse imaged in brightfield illumination (A), for GFP fluorescence before X-gal staining (B) and in brightfield after X-gal staining (C). The dorsal heart
region, where lysM was previously expressed, is outlined and labeled as ‘I’. The signals seen in the upper part of panel (B) represent autofluorescence (AF) due to
tissue compaction during preparation of the section. Scale bar=250 μm. (D, E) Magnification of area boxed in panels B and C. The outline of a region labeled ‘II’
indicates the position of X-gal+ GFP− cells in the inner myocardium of the IVS, where lysM expression is not maintained. Note the presence of a buffer of
mesenchymal cells (ms) between X-gal+ cells within the IVS and a group of dorsally located X-gal+ cells. Scale bar=100 μm.
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ters (Habets et al., 2003). The domain of lysozyme expression is
also distinct from the cardiac conduction system (Rentschler et
al., 2001), although it is possible that some of the cardiomyo-
cytes labeled in LysM ancestry mice are part of the IVS
component of this system. With respect to known cardiac
precursor populations, the localization of lysM+ cells to the
primitive ventricle at E9 precursors suggests that these cells are
a subset of the primary heart field, which is believed to be theFig. 7. LysM and lysP expression in the developing heart. The expression levels of
LysM-EGFPki/ki and wild type (wt) mice were determined by quantitative real-time P
experiments, each using RNA isolated from 3–5 embryos and 2–3 adult mice, respexclusive source of myocardial cells in this structure left
ventricle at this stage (Buckingham et al., 2005). On the other
hand, a recent study using transgenic mice with Cre
recombinase controlled by regulatory elements of the mef2C
gene indicated that the entire IVS is derived from the secondary
heart field, which also forms the right ventricle and the outflow
tract (Verzi et al., 2005). This apparent contradiction can be
resolved when assuming that the part of the primitive ventricle
that gives rise to the IVS is in fact derived from the secondarylysM and lysP in E9.5 hearts (A) and adult bone marrow (B) of lysM-deficient
CR analysis relative to β-actin. Error bars indicate the range of two independent
ectively.
Fig. 8. Summary diagram. (A) The drawing represents a para-sagittal section through an adult heart, with structures derived from the ventral and dorsal embryonic
domains of lysM expression indicated in light and dark green, respectively. (B) Representation of a whole mount of an E10.5 heart showing the ring of lysozyme
expressing cells. The ventral domain (VD) and the dorsal domain (DD) of lysozyme expressing cells are highlighted in light and dark green, respectively, which
contain the precursors of the corresponding color coded domains in panel A. The discontinuity within the ring seen at later developmental stages is indicated by the
dotted line. bc, Bulbus cordis; gr, bulbo-ventricular groove; IVS, interventricular septum; lv, left ventricle; pv, primitive ventricle and rv, right ventricle.
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contribute to the IVS but only little to the outer muscular layers
of left ventricle or the left ventricular freewall (see Fig. 1), also
suggests that septum and ventricle are derived from two
different primordia. Thus, lysM+ ventricular precursor cells do
not take part in the ballooning out that will give the left ventricle
its ultimate shape (Moorman and Christoffels, 2003). In the
developing human heart a population of myocardial cells
expressing the neuronal antigen G1N2 have been described that
surround the interventricular foramen in a similar fashion as
lysM+ cells (Lamers et al., 1992; Wessels et al., 1992) (see also
Fig. 5A). These cells might represent the human counterparts of
the murine cardiac progenitors described by us.
Dynamics of IVS formation
The tracing of lysozyme-positive cells by GFP expression
revealed the presence of labeled myocardial cells at E9, before
the initiation of ventricular septation and the formation of the
bulbo-ventricular groove. Thus, the IVS primordium is
specified earlier than hitherto appreciated (de la Cruz et al.,
1997; Kaufman and Bard, 1999).
Based on the analysis of staged LysM-EGFP embryos, the
first step of IVS morphogenesis consists of an anterior
movement of cells from the primitive ventricle, leading to
their accumulation in the nascent bulbo-ventricular groove
(Figs. 3E and 5A). This movement, which is initiated at E9.5
and essentially completed by E11.5, leads to a gap in the
initially continuous ring of GFP+ cells and thereby to two
independent domains of lysozyme expression, one located
ventrally and the other dorsally (Figs. 3 and 5). Importantly, X-
gal+ cells were absent in the inferior region of the left
ventricular free wall in adult LysM ancestry mice as well as
in E14.5 embryos (Figs. 1B–D and data not shown). This
strongly suggests that the shift in the location of GFP+ cells in
the ventral part of the primitive ventricle is caused by cellular
movements and not simply by a change in the expression
pattern of lysM. Nevertheless, it cannot be ruled out that some
of the lysM+ cells present at E9 disappear at later stages, such asby apoptosis. The second step in IVS formation is the
movement of lysM+ cells from the bulbo-ventricular groove
between E11.5 and E13.5 in a dorsal direction, thereby leading
to the closure of the interventricular foramen (Figs. 5B, C). The
localization of lysM+ cells to trabeculae in the E10 heart (Figs.
3F–H) and to the outer layers of the IVS at E14.5 (Fig. 6)
supports the notion that interventricular septation is achieved, at
least in part, by the compaction of trabeculae. This process has
been described previously in chicken embryos (Ben-Shachar et
al., 1985). Our observation that cardiomyocytes in the outer
layer of the IVS maintain lysozyme expression after septation is
completed suggests that septal growth is mediated by the
continuous addition of trabecular sheets mediates until postnatal
stages.
The analysis of adult LysM ancestry mice showed that
reporter gene expression preferentially labels the part of the IVS
that faces the lumen of the left ventricle (Figs. 1, 2, 8A). This is
not an artifact of the reporter system used since the ROSA26
locus is expressed in all parts of the embryonic myocardium
(Kitajima et al., 2006). We therefore conclude that the IVS is
heterogeneous in origin, deriving predominantly but not
exclusively from lysM-positive cardiomyocyte precursors.
This conclusion is consistent with the proposition that the
myocardium of the IVS originates both from the right and the
left ventricular primordium (Franco et al., 2006; Meilhac et al.,
2004). In fact, the asymmetrical distribution of reporter labeled
cells seen in the septum of adult LysM ancestry mice is
anticipated in the embryo, where lysM+ cells are part of the
primitive left ventricle (Figs. 3, 5, 8B). This observation
suggests that little left to right mixing of myocardial cells occurs
during interventricular septation, with the possible exception of
X-gal labeled adult cardiomyocytes in the side of the IVS that
faces the right ventricle.
In addition to their contribution to the IVS, lysM+ precursors
form parts of the left ventricular free wall, especially towards
the base of the heart (Figs. 1D, 8A), showing that these two
parts of the adult heart are developmentally related. In fact, they
can be traced to different domains within the ring of lysM+ cells
in the E9 heart (Figs. 3, 5, 8B): while most of the IVS derives
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the labeled cells in the ventricular free wall most likely originate
from the dorsal domain of lysozyme expression. The conclusion
that no IVS cardiomyocytes are derived from the dorsal domain
is supported by the presence of a buffer of X-gal-negative
mesenchymal cells between the X-gal+ cardiomyocytes in the
IVS and the region dorsal of the IVS, respectively (Figs. 6C, E).
This interpretation supports histological observations suggest-
ing that the region of the outflow tract contributes mesenchymal
cells but not muscle cells to the IVS (Kaufman and Bard, 1999).
Possible role of cardiac lysozyme
The specificity of lysM expression during heart development
suggests a role for this protein in IVS formation. However,
neither homozygous LysM-EGFP nor LysM ancestry mice,
which are lysM-deficient, showed any obvious cardiac defects or
histological abnormalities (S. Factor and M.S., unpublished
observations). The lack of an overt cardiac phenotype might be
caused by the expression of lysP in the heart (Fig. 7), a protein
that is highly related to lysM and in part rescues the antimicrobial
defects seen in lysM-deficient mice (Markart et al., 2004).
The best established role of lysozyme is the hydrolysis of
peptidoglycans in the wall of gram-positive bacteria
(Masschalck and Michiels, 2003). However, because of the
immuno-protected location of the embryo inside the mother, an
antimicrobial function of lysozyme expression in IVS pre-
cursors appears unlikely. A function of lysozyme in the heart
has been described recently. Thus, binding of lysozyme to
endocardial endothelial cells activates NO signaling and
appears to be involved in cardiac depression during septic
shock (Mink et al., 2003). Our finding that lysM+ cardiomyo-
cytes are localized in trabeculae and the outer layers of the
myocardium, structures that are in close contact with the
endocardium, therefore raises the possibility that lysozyme
participates in a cross-talk between endocardium and myocar-
dium during heart development. An alternative, but not
mutually exclusive, function is suggested by the observation
that lysozyme is first expressed in the trabeculae but then turned
off after they compact to form the inner layers of the IVS
myocardium (Fig. 6). Thus, lysozyme might play a role during
the coalescence of trabeculae. Finally, it cannot be excluded that
lysM and lysP, which are contained within a 20-kb region on
chromosome 10, have no function in cardiomyocyte precursors
and that their expression simply reflects co-regulation with yet
another, functionally relevant, gene. While groups of adjacent
similarly expressed genes have been described for Drosophila
(Spellman and Rubin, 2002), the inspection of the mouse
genome using the Ensembl database (www.ensemble.org)
revealed no gene with a specific cardiac function within
500 kb upstream or downstream of the lysozyme locus (M.S.
and T.G., unpublished observation). Our data therefore raise the
possibility that animals that lack both lysozyme genes have a
cardiac phenotype. However, to our knowledge lysP-deficient
mice have not been generated yet.
While lysozyme expression is not maintained in adult
cardiomyocytes, lysozyme expressing tissue macrophages arepresent in the adult heart, especially in the atria and the inner
surface of the ventricular chambers. The high abundance of
these cells and their alignment along cardiomyocytes are
striking (Figs. 2F, G and Suppl. Fig. 2). It will be interesting to
determine whether macrophages play a role in the homeostasis
of the heart, besides their established functions in the defense
against bacteria and the removal of apoptotic cells.
Regulation of cardiac lysM expression
The expression of lysM in macrophages is regulated by
myeloid transcription factors such as PU.1 and C/EBPβ (Faust
et al., 1999; Lefevre et al., 2003), prompting the question
whether the gene is similarly regulated in myocardial precursor
cells. This is not the case since LysM ancestry mice lacking
PU.1 or C/EBPβ show no reduction of cardiomyocyte labeling
(Suppl. Fig. 3). Furthermore, although lysM and lysP are both
expressed in the developing heart, only lysM is expressed in
bone marrow (Fig. 7). It is therefore likely that there is a distinct
transcriptional mechanism that regulates lysozyme expression
in the heart.
Since lysozyme expression in the embryonic heart is highly
asymmetrical (Fig. 5) it might be controlled by cardiac
transcription factors such as Hand1 and Hand2 (McFadden et
al., 2005) which define right versus left ventricular identity, or
the antagonistic pair Tbx5 and Tbx20, known to be involved in
the specification of the IVS (Takeuchi et al., 2003). Additional
possible regulators of lysozyme expression are the iroquois-
related homeobox genes Irx1 and Irx2, which are expressed in a
fashion reminiscent to lysM in the nascent IVS (Christoffels et
al., 2000). To determine whether any of these factors are
involved in the regulation of cardiac lysozyme expression, and
to further define the differences between lysM+ and lysM−
myocardial cells, it will be interesting to study the gene
expression pattern of IVS precursors isolated from LysM-EGFP
embryos.
In conclusion, the combined analysis of LysM-EGFP and
LysM ancestry mice has led to the identification of a novel
myocardial precursor population and to a description of the
dynamics of IVS formation. Based on our observations, LysM-
Cre mice should become useful for the specific deletion of
genes in the nascent IVS, permitting to probe their function in
cardiac septation. Such experiments might shed new light on the
molecular basis of ventricular septal defects in humans.
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